Miller Anestesia

480. Creswell LL: Postoperative atrial arrhythmias: Risk

factors and associated adverse outcomes. Semin

Thorac Cardiovasc Surg 11:303–307, 1999.

481. Creswell LL, Schuessler RB, Rosenbloom M, et al:

Hazards of postoperative atrial arrhythmias. Ann

Thorac Surg 56:539–549, 1993.

482. Hashimoto K, Ilstrup DM, Schaff HV: Influence of

clinical and hemodynamic variables on risk of

supraventricular tachycardia after coronary artery

bypass. J Thorac Cardiovasc Surg 101:56–65, 1991.

483. Brathwaite D, Weissman C: The new onset of atrial

arrhythmias following major noncardiothoracic

surgery is associated with increased mortality.

Chest 114:462–468, 1998.

484. Ommen SR, Odell JA, Stanton MS: Atrial arrhyth-

mias after cardiothoracic surgery. N Engl J Med

336:1429–1434, 1997.

485. Asher CR, Miller DP, Grimm RA, et al: Analysis of

risk factors for development of atrial fibrillation

early after cardiac valvular surgery. Am J Cardiol

82:892–895, 1998.

486. Zaman AG, Archbold RA, Helft G, et al: Atrial fibri-

llation after coronary artery bypass surgery: A

model for preoperative risk stratification. Circula-

tion 101:1403–1408, 2000.

487. Leitch JW, Thomson D, Baird DK, et al: The impor-

tance of age as a predictor of atrial fibrillation and

flutter after coronary artery bypass grafting. J

Thorac Cardiovasc Surg 100:338–342, 1990.

488. Chung MK: Cardiac surgery: Postoperative arr-

hythmias. Crit Care Med 28:N136–N144, 2000.

489. McLenachan JM, Dargie HJ: Ventricular arrhyth-

mias in hypertensive left ventricular hypertrophy.

Relationship to coronary artery disease, left ventri-

cular dysfunction, and myocardial fibrosis. Am J

Hypertens 3:735–740, 1990.

490. Mariscalco G, EngstromKG, Ferrarese S, et al: Rela-

tionship between atrial histopathology and atrial

fibrillation after coronary bypass surgery. J Thorac

Cardiovasc Surg 131:1364–1372, 2006.

491. Almassi GH, Schowalter T, Nicolosi AC, et al: Atrial

fibrillation after cardiac surgery: A major morbid

event? Ann Surg 226:501–511, 1997.

492. Valentine RJ, Rosen SF, Cigarroa JE, et al: The clini-

cal course of new-onset atrial fibrillation after elec-

tive aortic operations. J Am Coll Surg 193:499–504,

2001.

493. Huikuri HV, Yli-Mayry S, Korhonen UR, et al: Pre-

valence and prognostic significance of complex ven-

tricular arrhythmias after coronary arterial bypass

graft surgery. Int J Cardiol 27:333–339, 1990.

494. 2005 American Heart Association guidelines for

cardiopulmonary resuscitation and emergency car-

diovascular care, part 7.3: Management of sympto-

matic bradycardia and tachycardia. Circulation

112:IV-67-IV-77, 2005.

495. Atlee JL, Bernstein AD: Cardiac rhythm manage-

ment devices (part I): Indications, device selection,

and function. Anesthesiology 95:1265–1280, 2001.

496. Vuylsteke A, Feneck RO, Jolin-Mellgard A, et al:

Perioperative blood pressure control: A prospective

survey of patient management in cardiac surgery. J

Cardiothorac Vasc Anesth 14:269–273, 2000.

497. Levy JH: Management of systemic and pulmonary

hypertension. Tex Heart Inst J 32:467–471, 2005.

498. Oliver WC, Nuttall GA, Cherry KJ, et al: A compa-

rison of fenoldopam with dopamine and sodium

nitroprusside in patients undergoing cross-clam-

ping of the abdominal aorta. Anesth Analg 103:833–

840, 2006.

499. Cogliati AA, Vellutini R, Nardini A, et al: Fenoldo-

pam infusion for renal protection in high-risk

cardiac surgery patients: A randomized clinical

study. J Cardiothorac Vasc Anesth 21:847–850,

2007.

500. Chew ST, Newman MF, White WD, et al: Prelimi-

nary report on the association of apolipoprotein E

polymorphisms, with postoperative peak serum

creatinine concentrations in cardiac surgical

patients. Anesthesiology 93:325–331, 2000.

501. Conlon PJ, Stafford-Smith M, White WD, et al:

Acute renal failure following cardiac surgery.

Nephrol Dial Transplant 14:1158–1162, 1999.

502. Kuitunen A, Vento A, Suojaranta-Ylinen R, et al:

Acute renal failure after cardiac surgery: Evaluation

of the RIFLE classification. Ann Thorac Surg

81:542–546, 2006.

503. Puskas JD, Winston AD, Wright CE, et al: Stroke

after coronary artery operation: Incidence, correla-

tes, outcome, and cost. Ann Thorac Surg 69:1053–

1056, 2000.

504. McKhann GM, Grega MA, Borowicz LM Jr, et al:

Stroke and encephalopathy after cardiac surgery:

An update. Stroke 37:562–571, 2006.

505. Wityk RJ, Goldsborough MA, Hillis A, et al: Diffu-

sion- and perfusion-weighted brain magnetic reso-

nance imaging in patients with neurologic

complications after cardiac surgery. Arch Neurol

58:571–576, 2001.

506. Bucerius J, Gummert JF, Borger MA, et al: Predic-

tors of delirium after cardiac surgery delirium:

Effect of beating-heart (off-pump) surgery. J Thorac

Cardiovasc Surg 127:57–64, 2004.

507. Sharma AD, Parmley CL, Sreeram G, et al: Periphe-

ral nerve injuries during cardiac surgery: Risk

factors, diagnosis, prognosis, and prevention.

Anesth Analg 91:1358–1369, 2000.

508. Jellish WS, Blakeman B, Warf P, et al: Somatosensory

evoked potential monitoring used to compare the

effectofthreeasymmetricsternalretractorsonbrachial

plexus function. Anesth Analg 88:292–297, 1999.

509. Jellish WS, Martucci J, Blakeman B, et al: Somato-

sensory evoked potential monitoring of the brachial

plexus to predict nerve injury during internal

mammary artery harvest: Intraoperative compari-

sons of the Rultract and Pittman sternal retractors.

J Cardiothorac Vasc Anesth 8:398–403, 1994.

510. van Belle AF, Wesseling GJ, Penn OC, et al: Posto-

perative pulmonary function abnormalities after

coronary artery bypass surgery. Respir Med 86:195–

199, 1992.

511. Cimen S, Ozkul V, Ketenci B, et al: Daily comparison

of respiratory functions between on-pump and off-

pump patients undergoing CABG. Eur J Cardiotho-

rac Surg 23:589–594, 2003.

512. Cox CM, Ascione R, Cohen AM, et al: Effect of

cardiopulmonary bypass on pulmonary gas

exchange: A prospective randomized study. Ann

Thorac Surg 69:140–145, 2000.

513. Babik B, Asztalos T, Petak F, et al: Changes in respi-

ratory mechanics during cardiac surgery. Anesth

Analg 96:1280–1287, 2003.

514. Bauer M, Pasic M, Ewert R, et al: Ministernotomy

versus complete sternotomy for coronary bypass

operations: No difference in postoperative pulmo-

nary function. J Thorac Cardiovasc Surg 121:702–

707, 2001.

515. Aris A, Camara ML, Montiel J, et al: Ministerno-

tomy versus median sternotomy for aortic valve

replacement: A prospective, randomized study. Ann

Thorac Surg 67:1583–1587, 1999.

516. Lichtenberg A, Hagl C, Harringer W, et al: Effects of

minimal invasive coronary artery bypass on pulmo-

nary function and postoperative pain. Ann Thorac

Surg 70:461–465, 2000.

517. Ohkado A, Nakano K, Nakatani H, et al: The supe-

riority of pulmonary function after minimally inva-

sive direct coronary artery bypass. Jpn J Thorac

Cardiovasc Surg 50:66–69, 2002.

518. Gust R, Pecher S, Gust A, et al: Effect of patient-

controlled analgesia on pulmonary complications

after coronary artery bypass grafting. Crit Care Med

27:2218–2223, 1999.

519. O’Connor CJ: Pain relief and pulmonary morbidity

after cardiac surgery. Crit Care Med 27:2314–2316,

1999.

520. Weissman C: Pulmonary complications after

cardiac surgery. Semin Cardiothorac Vasc Anesth

8:185–211, 2004.

521. Shroyer AL, Coombs LP, Peterson ED, et al: The

Society of Thoracic Surgeons: 30-day operative

mortality and morbidity risk models. Ann Thorac

Surg 75:1856–1864, 2003.

522. Reddy SL, Grayson AD, Griffiths EM, et al: Logistic

risk model for prolonged ventilation after adult

cardiac surgery. Ann Thorac Surg 84:528–536, 2007.

523. Wahl GW, Swinburne AJ, Fedullo AJ, et al: Long-

term outcome when major complications follow

coronary artery bypass graft surgery: Recovery after

complicated coronary artery bypass graft surgery.

Chest 110:1394–1398, 1996.

524. Engoren MC, Habib RH, Zacharias A, et al: Effect

of blood transfusion on long-term survival after

cardiac operation. Ann Thorac Surg 74:1180–1186,

2002.

525. Surgenor SD, DeFoe GR, Fillinger MP, et al: Intrao-

perative red blood cell transfusion during coronary

artery bypass graft surgery increases the risk of

postoperative low-output heart failure. Circulation

114:I43–I48, 2006.

526. Ott E, Mazer CD, Tudor IC, et al: Coronary artery

bypass graft surgery–care globalization: The impact

of national care on fatal and nonfatal outcome. J

Thorac Cardiovasc Surg 133:1242–1251, 2007.

527. Ferraris VA, Ferraris SP, Saha SP, et al: Perioperative

blood transfusion and blood conservation in

cardiac surgery: The Society of Thoracic Surgeons

and the Society of Cardiovascular Anesthesiologists

clinical practice guideline. Ann Thorac Surg

83:S27–S86, 2007.

528. Pleym H, Stenseth R, Wahba A, et al: Prophylactic

treatment with desmopressin does not reduce

postoperative bleeding after coronary surgery in

patients treated with aspirin before surgery. Anesth

Analg 98:578–584, 2004.

529. Geisler T, Gawaz M: Variable response to clopido-

grel in patients with coronary artery disease. Semin

Thromb Hemost 33:196–202, 2007.

530. Gurbel PA, Tantry US: Clopidogrel resistance?

Thromb Res 120:311–321, 2007.

531. Danzi GB, Capuano C, Sesana M, et al: Variability

in extent of platelet function inhibition after admi-

nistration of optimal dose of glycoprotein IIb/IIIa

receptor blockers in patients undergoing a high-risk

percutaneous coronary intervention. Am J Cardiol

97:489–493, 2006.

532. Fergusson DA, Hébert PC, Mazer CD, et al: A com-

parison of aprotinin and lysine analogues in high-

risk cardiac surgery. N Engl J Med 358:2319–2331,

2008.

533. Ozier Y, Schlumberger S: Pharmacological appro-

aches to reducing blood loss and transfusions in the

surgical patient. Can J Anaesth 53:S21–S29, 2006.

534. DelRossi AJ, Cernaianu AC, Botros S, et al: Pro-

phylactic treatment of postperfusion bleeding using

EACA. Chest 96:27–30, 1989.

535. Horrow JC, Van Riper DF, Strong MD, et al: Hemos-

tatic effects of tranexamic acid and desmopressin

during cardiac surgery. Circulation 84:2063–2070,

1991.

536. Fiechtner BK, Nuttall GA, JohnsonME, et al: Plasma

tranexamic acid concentrations during cardiopul-

monary bypass. Anesth Analg 92:1131–1136, 2001.

537. Butterworth J, James RL, Lin Y, et al: Pharmacoki-

netics of epsilon-aminocaproic acid in patients

undergoing aortocoronary bypass surgery. Anesthe-

siology 90:1624–1635, 1999.

538. Kikura M, Levy JH, Tanaka KA, et al: A double-

blind, placebo-controlled trial of epsilon-aminoca-

proic acid for reducing blood loss in coronary

artery bypass grafting surgery. J Am Coll Surg

202:216–222, 2006.

539. Horrow JC, Van Riper DF, Strong MD, et al: The

dose-response relationship of tranexamic acid.

Anesthesiology 82:383–392, 1995.

540. Dowd NP, Karski JM, Cheng DC, et al: Pharmaco-

kinetics of tranexamic acid during cardiopulmo-

nary bypass. Anesthesiology 97:390–399, 2002.

541. Brown JR, Birkmeyer NJ, O’Connor GT: Meta-

analysis comparing the effectiveness and adverse

outcomes of antifibrinolytic agents in cardiac

surgery. Circulation 115:2801–2813, 2007.

542. Mangano DT, Miao Y, Vuylsteke A, et al: Mortality

associated with aprotinin during 5 years following

coronary artery bypass graft surgery. JAMA

297:471–479, 2007.

543. Royston D, Bidstrup BP, Taylor KM, et al: Effect of

aprotinin on need for blood transfusion after repeat

open-heart surgery. Lancet 2:1289–1291, 1987.

1740

Anestesia por subespecialidades en el adulto